MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Wednesday reported a loss of $28.6 million in its…MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Wednesday reported a loss of $28.6 million in its second quarter. On a per-share basis, the Montreal-based company said it had a loss of 21 cents. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share. The biotechnology company posted revenue of $559,000 in the period, also falling short of Street forecasts. _____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.